| Trial | FLAIR |
|---|---|
| Cancer Type | Haematological Cancers and Leukaemia |
| Hospital(s) | Altnagelvin Hospital, Belfast City Hospital, and Craigavon Hospital |
| Information | Front-Line therapy in CLL: Assessment of Ibrutinib + Rituximab |
 |
Click Here to view CancerHelpUK trial summary |
| Trial | M19-708 / VIALE-M |
|---|---|
| Cancer Type | Haematological Cancers and Leukaemia |
| Hospital(s) | Belfast City Hospital |
| Information | Randomized, Open-Label, 2-Arm, Multicenter, Phase 3 Study Of Venetoclax and Azacitidine Versus Best Supportive Care As Maintenance Therapy For Patients With Acute Myeloid Leukemia In First Remission After Conventional Chemotherapy |
| Trial | PACE |
|---|---|
| Cancer Type | Haematological Cancers and Leukaemia |
| Hospital(s) | Belfast City Hospital |
| Information | Patients with AML and COVID-19 Epidemiology |
| Trial | UKALL 14 |
|---|---|
| Cancer Type | Haematological Cancers and Leukaemia |
| Hospital(s) | Belfast City Hospital |
| Information | A randomised trial for adults with newly diagnosed acute lymphoblastic leukaemia |
|
Click Here to view CancerHelpUK trial summary |
| Trial | VICTOR |
|---|---|
| Cancer Type | Haematological Cancers and Leukaemia |
| Hospital(s) | Belfast City Hospital |
| Information | Venetoclax or Intensive Chemotherapy For Treatment of Favourable Risk Acute Myeloid Leukaemia: A Molecularly Guided Phase 2 Study |
